Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin PK and Safety in Children with Onchocerciasis
NCT03962062Phase 1Completed
- Sponsor
- Medicines Development for Global Health
- Start
- Mar 2021
- Primary completion
- May 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label trial of moxidectin in onchocerciasis (3 cohorts), sponsored by Medicines Development for Global Health. Primary endpoint: Area Under the Plasma Concentration Versus Time Curve at Day 28. Started Mar 2021; status: completed.
02
Drugs
moxidectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT03962062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03962062.